arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Bicara Therapeutics Inc.

BCAX Health Care Biotechnology: Pharmaceutical Preparations
$17.07
▼ -4.7% Today
as of Oct 23, 16:46 ET
Last 30 days -26.42% Sep 14 → Oct 23
$15.88 $17.84 $19.81 $21.78 $23.74 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$17.53
High
$17.85
Low
$16.98
Volume
$730,161
Avg Vol
$632,924
Mkt Cap
$1.2B
P/E (TTM)
—
Beta
—
52w High
$30.99
52w Low
$13.70
Div Yield
—
Shares Out
$66M

Recent Press Releases & News last 60 days · 3 items

Oct 10 · 10:09 Simply Wall St.
Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value
Oct 5 · 12:30 PR GlobeNewswire
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Sep 3 · 12:30 PR GlobeNewswire
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BCAX earnings at a glance

The options market is pricing a move of about ±28.4% after the report, a range of roughly $12.23 to $21.91 from today's $17.07. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.8% on average; after the most recent report on May 11, 2026 it moved +1.5%. That means options currently expect more movement than BCAX has typically delivered. BCAX beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 181%. The share price of $17.07 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$14
$31
19% of range
Avg surprise (last 4)
-32.4%
Avg reaction (last 2)
-3.3%
50% positive
Latest IV / EM
181%
EM ±28.4% · $18 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-38.23$-28.77$-19.31$-9.86$-0.40 Actual $-38.23Actual $-18.94Actual $-19.01Actual $-1.60Actual $-0.68Est $-0.40Actual $-0.50Est $-0.54Actual $-0.67Est $-0.55Actual $-0.93Est $-0.64Actual $-0.82 SepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-56M$-47M$-37M$-28M$-18M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.82 — — — — financials
Mon May 11, 2026Mar/2026 $-0.93 $-0.64 -45.3% -36.8% +1.5% earnings
Mon Nov 10, 2025Sep/2025 $-0.67 $-0.55 -21.8% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.50 $-0.54 +7.4% — — earnings
Tue May 13, 2025Mar/2025 $-0.68 $-0.40 -70.0% — -8.1% earnings
Mon Sep 30, 2024Sep 2024 $-1.60 — — — — financials
Sun Jun 30, 2024Jun 2024 $-19.01 — — — — financials
Sun Mar 31, 2024Mar 2024 $-18.94 — — — — financials
Sat Sep 30, 2023Sep 2023 $-38.23 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-60M$-60M—$-41M$-32M$-42M—$-21M
Net income$-55M$-56M—$-36M$-27M$-37M—$-17M
EPS (diluted)$-0.82$-0.93—$-0.67$-0.50$-0.68—$-1.60

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$97M$323M$97M$172M$437M$462M$490M$521M
Inventory————————
Total current assets$504M$545M$422M$297M$444M$471M$503M$522M
Total assets$512M$554M$431M$425M$454M$478M$510M$524M
Long-term debt————————
Total liabilities$43M$40M$30M$22M$18M$19M$18M$15M
Total equity$469M$514M$401M$403M$435M$459M$492M$510M

Implied volatility — last 90 days

33%137%242%346%451% Jun 07 — IV 117% · EM ±16.2%Jun 08 — IV 49% · EM ±6.4%Jun 09 — IV 33% · EM ±4.1%Jun 10 — IV 42% · EM ±4.9%Jun 11 — IV 213% · EM ±23.5%Jun 19 — IV 97% · EM ±21.5%Jun 22 — IV 74% · EM ±15.4%Jun 23 — IV 126% · EM ±25.8%Jun 24 — IV 99% · EM ±19.9%Jun 25 — IV 114% · EM ±22.4%Jun 26 — IV 115% · EM ±22.0%Jun 29 — IV 96% · EM ±17.0%Jul 07 — IV 137% · EM ±18.1%Jul 16 — IV 451% · EM ±18.8%Jul 20 — IV 67% · EM ±15.8%Jul 21 — IV 93% · EM ±21.7%Jul 22 — IV 88% · EM ±20.0%Jul 23 — IV 99% · EM ±22.2%Jul 24 — IV 65% · EM ±14.4%Jul 27 — IV 96% · EM ±20.1%Jul 28 — IV 70% · EM ±14.2%Jul 29 — IV 71% · EM ±14.2%Jul 30 — IV 63% · EM ±12.3%Jul 31 — IV 64% · EM ±12.2%Aug 03 — IV 74% · EM ±13.1%Aug 04 — IV 111% · EM ±19.2%Aug 05 — IV 71% · EM ±11.8%Aug 06 — IV 155% · EM ±25.1%Aug 07 — IV 123% · EM ±19.2%Aug 10 — IV 141% · EM ±19.5%Aug 11 — IV 196% · EM ±25.9%Aug 13 — IV 190% · EM ±22.4%Aug 14 — IV 80% · EM ±8.9%Aug 17 — IV 65% · EM ±5.4%Aug 18 — IV 47% · EM ±3.4%Aug 20 — IV 142% · EM ±5.9%Aug 24 — IV 89% · EM ±18.7%Aug 25 — IV 58% · EM ±11.9%Aug 26 — IV 101% · EM ±20.2%Aug 27 — IV 66% · EM ±13.0%Aug 28 — IV 68% · EM ±13.0%Aug 31 — IV 62% · EM ±11.0%Sep 01 — IV 71% · EM ±12.2%Sep 02 — IV 74% · EM ±12.3%Sep 03 — IV 64% · EM ±10.3%Sep 04 — IV 58% · EM ±9.1%Sep 07 — IV 65% · EM ±9.1%Sep 08 — IV 97% · EM ±12.9%Sep 09 — IV 89% · EM ±11.2%Sep 10 — IV 60% · EM ±7.1%Sep 11 — IV 63% · EM ±7.0%Sep 14 — IV 103% · EM ±8.6%Sep 15 — IV 79% · EM ±5.7%Sep 16 — IV 50% · EM ±3.0%Sep 17 — IV 85% · EM ±3.5%Sep 21 — IV 114% · EM ±23.9%Sep 22 — IV 92% · EM ±18.9%Sep 23 — IV 133% · EM ±26.6%Sep 24 — IV 145% · EM ±28.3%Sep 25 — IV 147% · EM ±28.1%Oct 01 — IV 170% · EM ±27.5%Oct 02 — IV 181% · EM ±28.4%

Sector peers

DMRA
Damora Therapeutics, Inc.
$1.2B $21.09-2.0%
ORIC
Oric Pharmaceuticals, Inc.
$1.3B $13.17-4.9%
MNKD
MannKind Corporation
$1.1B $3.19+4.6%
JANX
Janux Therapeutics, Inc.
$1.1B $16.66-1.6%
OPK
Opko Health, Inc.
$1.0B $1.63+1.9%
TYRA
Tyra Biosciences, Inc.
$1.4B $20.45-0.7%

BCAX earnings FAQ

What is BCAX's expected move for earnings?

Options currently price a move of about ±28.4%, or $4.84 per share either way from $17.07.

How does BCAX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.8%, up 1 times and down 1 times.

What is BCAX's implied volatility?

BCAX's at-the-money implied volatility is about 181% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in